Affinity and specificity of levamlodipine-human serum albumin interactions: insights into its carrier function.

Article Details

Citation

Copy to clipboard

Liu Z, Zheng X, Yang X, Wang E, Wang J

Affinity and specificity of levamlodipine-human serum albumin interactions: insights into its carrier function.

Biophys J. 2009 May 20;96(10):3917-25. doi: 10.1016/j.bpj.2008.12.3965.

PubMed ID

19450464 [ View in PubMed

]

Abstract

The affinity and specificity of drugs with human serum albumin (HSA) are crucial factors influencing the bioactivity of drugs. To gain insight into the carrier function of HSA, the binding of levamlodipine with HSA has been investigated as a model system by a combined experimental and theoretical/computational approach. The fluorescence properties of HSA and the binding parameters of levamlodipine indicate that the binding is characterized by one binding site with static quenching mechanism, which is related to the energy transfer. As indicated by the thermodynamic analysis, hydrophobic interaction is the predominant force in levamlodipine-HSA complex, which is in agreement with the computational results. And the hydrogen bonds can be confirmed by computational approach between levamlodipine and HSA. Compared to predicted binding energies and binding energy spectra at seven sites on HSA, levamlodipine binding HSA at site I has a high affinity regime and the highest specificity characterized by the largest intrinsic specificity ratio (ISR). The binding characteristics at site I guarantee that drugs can be carried and released from HSA to carry out their specific bioactivity. Our concept and quantification of specificity is general and can be applied to other drug-target binding as well as molecular recognition of peptide-protein, protein-protein, and protein-DNA interactions.

DrugBank Data that Cites this Article

Drugs

Levamlodipine

Drug Carriers

Drug	Carrier	Kind	Organism	Pharmacological Action	Actions
Levamlodipine	Serum albumin	Protein	Humans	Unknown	Binder	Details